JP2023515271A5 - - Google Patents
Info
- Publication number
- JP2023515271A5 JP2023515271A5 JP2022564482A JP2022564482A JP2023515271A5 JP 2023515271 A5 JP2023515271 A5 JP 2023515271A5 JP 2022564482 A JP2022564482 A JP 2022564482A JP 2022564482 A JP2022564482 A JP 2022564482A JP 2023515271 A5 JP2023515271 A5 JP 2023515271A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- acid sequence
- seq
- pharmaceutical product
- region includes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662440180P | 2016-12-29 | 2016-12-29 | |
| US16/856,407 US11174307B2 (en) | 2016-12-29 | 2020-04-23 | Methods and compositions for treating virus-associated inflammation |
| US16/856,407 | 2020-04-23 | ||
| PCT/US2021/028847 WO2021217004A2 (en) | 2016-12-29 | 2021-04-23 | Methods and compositions for treating virus-associated inflammation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023515271A JP2023515271A (ja) | 2023-04-12 |
| JP2023515271A5 true JP2023515271A5 (https=) | 2024-05-07 |
Family
ID=62710025
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019536086A Pending JP2020503345A (ja) | 2016-12-29 | 2017-12-28 | 肺におけるインフラマソーム活性及び炎症をモジュレートする方法 |
| JP2022564482A Pending JP2023515271A (ja) | 2016-12-29 | 2021-04-23 | ウイルス関連炎症を処置するための方法及び組成物 |
| JP2022181180A Pending JP2023016835A (ja) | 2016-12-29 | 2022-11-11 | 肺におけるインフラマソーム活性及び炎症をモジュレートする方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019536086A Pending JP2020503345A (ja) | 2016-12-29 | 2017-12-28 | 肺におけるインフラマソーム活性及び炎症をモジュレートする方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022181180A Pending JP2023016835A (ja) | 2016-12-29 | 2022-11-11 | 肺におけるインフラマソーム活性及び炎症をモジュレートする方法 |
Country Status (16)
| Country | Link |
|---|---|
| US (5) | US20190336598A1 (https=) |
| EP (2) | EP3562506A4 (https=) |
| JP (3) | JP2020503345A (https=) |
| KR (1) | KR20200013630A (https=) |
| CN (1) | CN110461356A (https=) |
| AU (1) | AU2017386550A1 (https=) |
| BR (1) | BR112019013463A2 (https=) |
| CA (2) | CA3048864A1 (https=) |
| CO (1) | CO2019008087A2 (https=) |
| IL (1) | IL267685A (https=) |
| MX (1) | MX2019007916A (https=) |
| PH (1) | PH12019501549A1 (https=) |
| RU (1) | RU2019123160A (https=) |
| SG (1) | SG10202106385XA (https=) |
| WO (2) | WO2018126009A1 (https=) |
| ZA (1) | ZA201904861B (https=) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20240060995A1 (en) * | 2012-02-06 | 2024-02-22 | University Of Miami | Innate immune proteins as biomarkers for traumatic brain injury in adult and pediatric patients |
| WO2021222263A2 (en) * | 2020-04-27 | 2021-11-04 | University Of Miami | Compositions and methods for treating inflammasome related diseases or conditions |
| US11840565B2 (en) | 2016-12-29 | 2023-12-12 | University Of Miami | Methods and compositions for treating virus-associated inflammation |
| RU2019123160A (ru) | 2016-12-29 | 2021-01-29 | Юниверсити Оф Майами | Способ модуляции активности инфламмасом и воспаления в легком |
| SG11202013176VA (en) | 2018-07-03 | 2021-01-28 | Univ Miami | Compositions and methods for treating inflammasome related diseases or conditions |
| EP3938781B8 (en) * | 2019-03-13 | 2026-01-14 | Fundación para la Formación e Investigación Sanitarias de la Región De Murcia (FFIS) | In vitro method for obtaining clinical data in patients suffering from an inflammatory disease |
| WO2021097084A1 (en) * | 2019-11-12 | 2021-05-20 | The Uab Research Foundation | Methods for treating immunosuppression and diseases associated with immunosuppression |
| CN111363847B (zh) * | 2020-02-12 | 2021-06-29 | 广州微远医疗器械有限公司 | 基于CRISPR技术的2019-nCoV快速检测引物组及其用途 |
| CN113278730B (zh) * | 2020-02-20 | 2022-03-25 | 中元汇吉生物技术股份有限公司 | 一种新型冠状病毒检测试剂盒、用途及其使用方法 |
| CN115551512A (zh) * | 2020-03-19 | 2022-12-30 | 南洋理工大学 | 包含nlrp1炎性体激活抑制剂的化合物或组合物用于治疗人气道炎症的用途 |
| CN111289745A (zh) * | 2020-03-25 | 2020-06-16 | 中山生物工程有限公司 | 新型冠状病毒IgM抗体酶联免疫检测试剂盒及其检测方法 |
| KR102658146B1 (ko) * | 2020-03-26 | 2024-04-18 | 경북대학교 산학협력단 | Pannexin3을 포함하는 근육 손상 진단용 바이오마커 조성물 및 이를 이용한 진단방법 |
| CN111529707B (zh) * | 2020-04-29 | 2021-04-23 | 威海市立医院 | Gsdmd抑制剂在制备治疗幽门螺杆菌感染的药物中的应用 |
| CN111777684A (zh) * | 2020-06-09 | 2020-10-16 | 重庆君同生物技术有限公司 | 冠状病毒串联表位蛋白所诱导抗体的制备方法及其应用 |
| IL299793A (en) * | 2020-07-09 | 2023-03-01 | Remedy Cell Ltd | Methods for treating acute respiratory distress syndrome and cytokine storm |
| KR102582417B1 (ko) * | 2020-11-06 | 2023-09-26 | 한국과학기술원 | 인플라마솜 어댑터 단백질(asc)의 중합체화 도메인에 결합하는 신규한 폴리펩타이드 및 이의 용도 |
| EP4286406A4 (en) | 2021-01-29 | 2025-07-23 | Illimis Therapeutics Inc | FUSION MOLECULE WITH NON-INFLAMMATORY PHAGOCYTOSIS-INDUCING ACTIVITY |
| CN113109569B (zh) * | 2021-03-05 | 2022-08-19 | 李朴 | Gsdmd作为生物标志物在胸腔积液相关疾病鉴别诊断及疗效评估上的用途 |
| KR102673132B1 (ko) * | 2021-04-20 | 2024-06-12 | 아주대학교산학협력단 | 염증성 질환 치료를 위한 nlrp3 인플라마좀 억제 펩타이드 |
| US20230027739A1 (en) | 2021-05-10 | 2023-01-26 | Entrada Therapeutics, Inc. | Antigen-binding and antigen degradation constructs |
| CA3226977A1 (en) * | 2021-08-25 | 2023-03-02 | R.P. Scherer Technologies, Llc | Antibodies having humanized framework regions |
| CN115819548B (zh) * | 2021-11-16 | 2023-09-01 | 北京美德泰康生物科技有限公司 | 一种检测炎症相关疾病的标志物和方法 |
| WO2024006457A1 (en) * | 2022-06-29 | 2024-01-04 | University Of South Florida | Method of treating long-covid induced neurologic diseases |
| WO2024114906A1 (en) | 2022-11-30 | 2024-06-06 | Mabylon Ag | Antibodies against apoptosis-associated speck-like protein containing a card (asc) and uses thereof |
| WO2024248287A1 (ko) * | 2023-06-01 | 2024-12-05 | 한양대학교 에리카산학협력단 | 결핵균 유래 폴리펩타이드를 포함하는 염증성 질환 치료용 약학 조성물 |
| WO2025081130A1 (en) * | 2023-10-12 | 2025-04-17 | University Of Miami | Use of anti-asc antibody in the treating of ocular disorders |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040018194A1 (en) | 2000-11-28 | 2004-01-29 | Francisco Joseph A. | Recombinant anti-CD30 antibodies and uses thereof |
| US7611707B2 (en) | 2004-04-29 | 2009-11-03 | Otsuka Pharmaceutical Co., Ltd. | Glycoprotein VI antibodies and methods thereof |
| US7811563B2 (en) | 2004-10-25 | 2010-10-12 | Northwestern University | Anti-addl antibodies and uses thereof |
| TW200636064A (en) | 2004-10-28 | 2006-10-16 | Centocor Inc | Anti-respiratory syncytial virus antibodies, antigens and uses thereof |
| KR20100014588A (ko) | 2007-02-27 | 2010-02-10 | 제넨테크, 인크. | 길항제 ｏｘ40 항체 및 염증성 및 자가면역 질환의 치료에서의 이의 용도 |
| WO2009014863A2 (en) * | 2007-06-29 | 2009-01-29 | Thomas Jefferson University | Asc and pyrin-asc pyroptosomes and uses thereof |
| US8685400B2 (en) * | 2007-07-30 | 2014-04-01 | University Of Miami | Modulating inflammasome activity and inflammation in the central nervous system |
| WO2010003092A1 (en) * | 2008-07-03 | 2010-01-07 | University Of Massachusetts | Methods and compositions for reducing inflammation and treating inflammatory disorders |
| EP2475380A1 (en) * | 2009-09-11 | 2012-07-18 | Protaffin Biotechnologie AG | Composition for treatment of cxcl8-mediated lung inflammation |
| SMT202000095T1 (it) | 2010-05-14 | 2020-03-13 | Amgen Inc | Formulazioni di anticorpi anti-sclerostina ad alta concentrazione |
| IT1406201B1 (it) | 2010-12-10 | 2014-02-14 | Univ Degli Studi Trieste | Biomarcatori per la diagnosi della sclerosi multipla |
| EP2684051B1 (en) | 2011-03-11 | 2016-04-27 | Roche Diagniostics GmbH | Asc as marker for chronic obstructive pulmonary disease (copd) |
| EP2812697B1 (en) | 2012-02-06 | 2017-03-22 | University of Miami | Innate immune proteins as biomarkers for cns injury |
| TWI480044B (zh) | 2012-03-16 | 2015-04-11 | Taichung Veterans General Hospital | A high molecular weight heparin or low molecular weight heparin for the preparation of a composition for at least two consecutive days of administration to improve the allergic constitution |
| US20140314746A1 (en) * | 2013-03-13 | 2014-10-23 | Philadelphia Health And Education Corporation, d/b/a Drexel University College of Medicine | Methods for treating or preventing fibrosis in subjects afflicted with scleroderma |
| HK1219512A1 (zh) * | 2013-05-17 | 2017-04-07 | F. Hoffmann-La Roche Ag | 用於诊断和治疗炎性肠病的方法 |
| JP6359013B2 (ja) * | 2013-07-29 | 2018-07-18 | 国立大学法人 鹿児島大学 | １，５−ｄ−アンヒドロフルクトースを含むアポトーシス関連スペック様カード蛋白質の機能阻害薬 |
| AU2015204558B2 (en) * | 2014-01-10 | 2020-04-30 | Avalyn Pharma Inc. | Aerosol pirfenidone and pyridone analog compounds and uses thereof |
| US10143709B2 (en) * | 2014-05-06 | 2018-12-04 | Indiana University Research And Technology Corporation | Use of ASC and ASC-CM to treat ARDS, SARS, and MERS |
| EP3183582B1 (en) | 2014-08-18 | 2020-02-12 | The United States of America, as represented by The Secretary, Department of Health and Human Services | Biomarkers for diagnosis and management of neuro-immunological diseases |
| US20160263183A1 (en) | 2015-03-10 | 2016-09-15 | Brown University | Methods for treating lung disease |
| AU2016260190A1 (en) * | 2015-05-12 | 2017-11-23 | The Regents Of The University Of California | Peptide treatment for inflammation and fibrosis |
| US10195170B2 (en) | 2015-08-17 | 2019-02-05 | Twi Biotechnology, Inc. | Methods for inhibiting expression of ASC, expression of NLRP3, and/or formation of NLRP3 inflammasome complex using diacerein or its analogs |
| KR101948048B1 (ko) | 2016-12-08 | 2019-02-14 | 한양대학교 에리카산학협력단 | 톡소포자충 ｇｒａ７ 항원 유래 재조합 단백질을 유효성분으로 포함하는 결핵 예방 또는 치료용 약학 조성물 |
| RU2019123160A (ru) * | 2016-12-29 | 2021-01-29 | Юниверсити Оф Майами | Способ модуляции активности инфламмасом и воспаления в легком |
| WO2019060516A1 (en) | 2017-09-20 | 2019-03-28 | University Of Miami | METHOD FOR DETECTION OF INFLAMMASOME PROTEINS AS BIOMARKERS OF NEUROLOGICAL DISORDERS |
| SG11202013176VA (en) | 2018-07-03 | 2021-01-28 | Univ Miami | Compositions and methods for treating inflammasome related diseases or conditions |
-
2017
- 2017-12-28 RU RU2019123160A patent/RU2019123160A/ru unknown
- 2017-12-28 WO PCT/US2017/068713 patent/WO2018126009A1/en not_active Ceased
- 2017-12-28 MX MX2019007916A patent/MX2019007916A/es unknown
- 2017-12-28 JP JP2019536086A patent/JP2020503345A/ja active Pending
- 2017-12-28 BR BR112019013463-8A patent/BR112019013463A2/pt not_active IP Right Cessation
- 2017-12-28 KR KR1020197022320A patent/KR20200013630A/ko not_active Ceased
- 2017-12-28 AU AU2017386550A patent/AU2017386550A1/en not_active Abandoned
- 2017-12-28 SG SG10202106385XA patent/SG10202106385XA/en unknown
- 2017-12-28 CN CN201780087090.4A patent/CN110461356A/zh active Pending
- 2017-12-28 EP EP17888678.4A patent/EP3562506A4/en not_active Withdrawn
- 2017-12-28 CA CA3048864A patent/CA3048864A1/en active Pending
- 2017-12-28 US US16/474,708 patent/US20190336598A1/en not_active Abandoned
-
2018
- 2018-07-03 US US16/026,482 patent/US10703811B2/en active Active
-
2019
- 2019-06-26 IL IL267685A patent/IL267685A/en unknown
- 2019-07-01 PH PH12019501549A patent/PH12019501549A1/en unknown
- 2019-07-24 ZA ZA2019/04861A patent/ZA201904861B/en unknown
- 2019-07-25 CO CONC2019/0008087A patent/CO2019008087A2/es unknown
-
2020
- 2020-04-13 US US16/847,054 patent/US10961306B2/en active Active
- 2020-04-23 US US16/856,407 patent/US11174307B2/en active Active
-
2021
- 2021-04-23 WO PCT/US2021/028847 patent/WO2021217004A2/en not_active Ceased
- 2021-04-23 JP JP2022564482A patent/JP2023515271A/ja active Pending
- 2021-04-23 EP EP21792075.0A patent/EP4139348A4/en active Pending
- 2021-04-23 CA CA3176518A patent/CA3176518A1/en active Pending
- 2021-06-25 US US17/358,582 patent/US20210324065A1/en not_active Abandoned
-
2022
- 2022-11-11 JP JP2022181180A patent/JP2023016835A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023515271A5 (https=) | ||
| JP2021521843A5 (https=) | ||
| JP2024016177A5 (https=) | ||
| FI4045533T3 (fi) | Ihmisen monoklonaalisia vasta-aineita vakavalle akuutille koronavirus 2 -hengityselinoireyhtymälle (sars-cov-2) | |
| JP2020518599A5 (https=) | ||
| JP2020518600A5 (https=) | ||
| JP2021528092A5 (https=) | ||
| JP2018535650A5 (https=) | ||
| RU2011105062A (ru) | Нейтрализующие антитела против вируса гриппа а и их использование | |
| JP2017514461A5 (https=) | ||
| JP2009511480A5 (https=) | ||
| JP2018521691A5 (https=) | ||
| JP2014519334A5 (https=) | ||
| JP2021527640A5 (https=) | ||
| JP2020522280A5 (https=) | ||
| JP2012532851A5 (https=) | ||
| JP2023538369A5 (https=) | ||
| JP2020522281A5 (https=) | ||
| JP2021501579A5 (https=) | ||
| RU2017144629A (ru) | Тромбин-связывающие молекулы антител и их применение | |
| JP2024518536A5 (https=) | ||
| JP2025087764A5 (https=) | ||
| JP2020504135A5 (https=) | ||
| JP2018529328A5 (https=) | ||
| JP2023537078A5 (https=) |